Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 28, 2011; 17(40): 4517-4522
Published online Oct 28, 2011. doi: 10.3748/wjg.v17.i40.4517
Published online Oct 28, 2011. doi: 10.3748/wjg.v17.i40.4517
Table 1 Demographic and clinical characteristics of the patients (mean ± SD)
| Parameter | n (%) |
| Male | 60 (71.4) |
| Female | 24 (28.6) |
| Age (yr) | 38.6 ± 10.9 |
| HBeAg (+) | 21 (25.0) |
| HBeAg (-) | 63 (75.0) |
| Hypertension | 6 (7.1) |
| Diabetes mellitus | 3 (3.5) |
| BMI (kg/m2) | 27.4 ± 4.40 |
| < 25 | 28 (33.3) |
| 25-30 | 34 (40.5) |
| > 30 | 22 (26.2) |
| Glucose (mg/dL) | 101.4 ± 26.0 |
| Cholesterol (mg/dL) | 182.7 ± 29.3 |
| Triglyceride (mg/dL) | 131.0 ± 55.4 |
| AST (IU/L) | 103.3 ± 39.5 |
| ALT (IU/L) | 136.8 ± 47.2 |
| GGT (IU/L) | 49.9 ± 41.1 |
| ALP (IU/L) | 91.9 ± 26.5 |
| HBV-DNA (copies/mL × 104) | 5502.9 ± 11889.7 |
- Citation: Ateş F, Yalnız M, Alan S. Impact of liver steatosis on response to pegylated interferon therapy in patients with chronic hepatitis B. World J Gastroenterol 2011; 17(40): 4517-4522
- URL: https://www.wjgnet.com/1007-9327/full/v17/i40/4517.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i40.4517